Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Chimerix (CMRX.US)$ keep going up

$Chimerix (CMRX.US)$ keep going up
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
1
+0
1
Translate
Report
1226 Views
Comment
Sign in to post a comment
  • Dan’l : ** Shares of biotech Chimerix CMRX
    rise 171.68% to $2.35 after the bell
    ** Company plans to submit an application seeking FDA's accelerated approval in the U.S. for its drug dordaviprone as a treatment for a type of glioma before year-end
    ** Adds it will be ready for a U.S. launch as early as Q3 2025
    ** CMRX is seeking approval of dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse
    glioma, a type of tumor that forms in the brain
    ** Up to last close, stock down ~10% YTD
    (Reporting bv Sriparna Rov